NEW YORK--(BUSINESS WIRE)--OrbiMed is pleased to announce that, as part of ongoing succession
planning, Samuel D. Isaly has transferred his controlling interest in
[...]
NEW YORK--(BUSINESS WIRE)--OrbiMed is pleased to announce that, as part of ongoing succession
planning, Samuel D. Isaly has transferred his controlling interest in
[...]
NEW YORK--(BUSINESS WIRE)--OrbiMed, a leading investment firm focused on the healthcare sector,
announced the closing of its third Asia-focused private equity fund,
[...]
NEW YORK--(BUSINESS WIRE)--OrbiMed, a leading investment firm focused on the healthcare sector,
announced the closing of its third Asia-focused private equity fund,
[...]
NEW YORK--(BUSINESS WIRE)--OrbiMed Advisors LLC (“OrbiMedâ€), on behalf of its clients, has
evaluated the proxy proposals from both Immunomedics, Inc.
[...]